Inclusion Criteria:  Capable of giving informed consent; Capable and willing to follow all study related procedures; Women and men >18 years of age; Diagnosis of hip pain; Baseline VAS score of >5; >50% temporary relief from temporary nerve diagnostic evaluation; No evidence of anatomic abnormalities that could jeopardize device placement; Able to operate programmer, recharger, study assessments and provide accurate responses; Appropriate candidate for the implant procedure.  Exclusion Criteria:  An active implantable electronic device regardless of whether stimulation is ON or OFF; Pregnant or plan to become pregnant during study; Less than 1-year post-partum and/or are breast-feeding; Symptoms existing for less than 6 months; Multiple complaints that will not be amenable to study; Current diagnosis of a Neurological disease; Daily opioid usage exceeding CDC recommendations; Dependency on utilizing wearable or transcutaneous monitoring device (hearing aids, continuous glucose monitors, etc.); Conditions requiring recurring MRI evaluation or diathermy procedures; Uncontrolled diabetes (HbA1C > 8.5); Known or suspected substance abuse within the last 2-years; Uncontrolled major depression or uncontrolled psychiatric disorders; Worker's compensation claimants; History of adverse reaction to local anesthetic drugs; History of coagulopathy or bleeding disorder; Anatomical restrictions such that device placement is not possible; Chronic or acute conditions that could interfere with the interpretations of the outcome assessment for pain and bodily function; Have a life expectancy of less than 1-year; Neurogenic or vascular claudication; Inability to achieve appropriate positioning and inability to understand informed consent and protocol; Deemed unsuitable for enrollment by investigator based on history or physical examination.